• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Humacyte (HUMA)

Common Shares
Sell: $1.15|Buy: $1.17|Change: 0.07 (6.49%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Address




Website

https://www.humacyte.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Humacyte Inc Third Quarter Earnings Conference Call for 20262026-11-12T08:00:00
Humacyte Inc Third Quarter Earnings Results for 20262026-11-12T00:00:00
Humacyte Inc Second Quarter Earnings Conference Call for 20262026-08-11T08:00:00
Humacyte Inc Second Quarter Earnings Results for 20262026-08-11T00:00:00
Humacyte Inc Annual General Meeting for 20262026-06-10T08:00:00
Humacyte Inc First Quarter Earnings Conference Call for 20262026-05-13T08:30:00
Humacyte Inc First Quarter Earnings Results for 20262026-05-13T00:00:00
Humacyte Inc Annual Report for 20252026-03-31T00:00:00
Humacyte Inc Fourth Quarter Earnings Conference Call for 20252026-03-27T08:30:00
Humacyte Inc Fourth Quarter Earnings Results for 20252026-03-27T00:00:00

Previous key dates

NameKey Date
Humacyte Inc Annual Report for 20252026-03-31T00:00:00
Humacyte Inc Fourth Quarter Earnings Conference Call for 20252026-03-27T08:30:00
Humacyte Inc Fourth Quarter Earnings Results for 20252026-03-27T00:00:00
Humacyte Inc Third Quarter Earnings Conference Call for 20252025-11-12T08:00:00
Humacyte Inc Third Quarter Earnings Result for 20252025-11-12T00:00:00
Humacyte Inc Second Quarter Earnings Conference Call for 20252025-08-11T08:00:00
Humacyte Inc Second Quarter Earnings Results for 20252025-08-11T00:00:00
Humacyte Inc Annual General Meeting for 20252025-06-10T08:00:00
H.C. Wainwright 3rd Annual BioConnect Investor Conference2025-05-20T12:30:00
Humacyte Inc First Quarter Earnings Conference Call for 20252025-05-13T08:30:00
Humacyte Inc First Quarter Earnings Result for 20252025-05-13T00:00:00
Humacyte Inc Annual Report for 20242025-03-31T00:00:00
Humacyte Inc Fourth Quarter Earnings Conference Call for 20242025-03-28T08:30:00
Humacyte Inc Fourth Quarter Earnings Results for 20242025-03-28T00:00:00
TD Cowen 45th Annual Health Care Conference2025-03-04T15:10:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.